drugset / Trial / NCT01703793

Safety and Efficacy Study in Subjects With Seborrheic Dermatitis

NCT01703793 ↗

Phase 2 Completed 240 enrolled Medicis Global Service Corporation
RandomizedParallel-groupDouble-blindTreatment

Summary

The purpose of this study is to determine if two test products are safe and effective in the treatment of seborrheic dermatitis.

Timeline

Start
2012-09
Primary completion
2013-01
Completion
2013-01

Drugs

EvaluationDrugModalityDoseRoute
Subject Product 10156 Unknown — —
Subject Product 49778 Unknown — —

Indications